SCHEMBL19923741

SCHEMBL19923741

CC[Si](CC)(CC)N1C(=O)N(C)C(c2ccccc2)(c2ccccc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
PKM P14618 1/20 0.38
LMNA P02545 3/20 0.38
BACE1 P56817 4/20 0.37
BACE2 Q9Y5Z0 2/20 0.37
REN P00797 1/20 0.36
APP P05067 1/20 0.36
HTR1A P08908 2/20 0.34
HTR7 P34969 2/20 0.34
HTR6 P50406 2/20 0.34
ALDH1A1 P00352 3/20 0.34
GAA P10253 2/20 0.33
ELANE P08246 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
MPI P34949 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923734 0.89 TSHR (0.38) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923551 0.84 BACE1 (0.37) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923661 0.83 BACE1 (0.39) TSHRCYP2C19LMNABACE1BACE2
SCHEMBL19923549 0.83 TSHR (0.38) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923735 0.82 PKM (0.41) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923554 0.82 ELANE (0.38) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923427 0.82 MITF (0.41) TSHRCYP2C19PKMLMNABACE1
SCHEMBL19923400 0.82 SMN1; SMN2 (0.36) TSHRCYP2C19LMNABACE1BACE2
SCHEMBL19923625 0.80 NPSR1 (0.42) TSHRCYP2C19HTR1AHTR7HTR6
SCHEMBL19923464 0.79 PKM (0.39) TSHRCYP2C19PKMLMNABACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN TSHR 4786/4885CYP2C19 1347/4885PKM 1356/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM TSHR 4794/4885CYP2C19 1259/4885PKM 1417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.